GREGoRi Innovation Projects (U01 Clinical Trial Optional)

The summary for the GREGoRi Innovation Projects (U01 Clinical Trial Optional) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

GREGoRi Innovation Projects (U01 Clinical Trial Optional): The Genomics Research to Elucidate the Genetics of Rare Diseases:innovation (GREGoRi) initiative seeks to accelerate a paradigm shift in rare disease diagnosis by reimagining the tools, molecular technologies and analytical approaches used to identify the causal gene(s) and/or variant(s) underlying rare genetic disorders. This Notice of Funding Opportunity is intended to stimulate the development and testing of highly innovative experimental or computational approaches for rare disease diagnosis, that have the potential to make transformative improvements to the current state of the art.

Federal Grant Title:	GREGoRi Innovation Projects (U01 Clinical Trial Optional)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-HG-27-013
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.172
CFDA Descriptions:	Information not provided
Current Application Deadline:	October 30th, 2026
Original Application Deadline:	October 30th, 2026
Posted Date:	June 18th, 2026
Creation Date:	June 18th, 2026
Archive Date:	December 9th, 2026
Total Program Funding:	$7,500,000
Maximum Federal Grant Award:	$500,000
Minimum Federal Grant Award:	$3
Expected Number of Awards:	10
Cost Sharing or Matching:	No
Last Updated:	June 18th, 2026

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility: Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Grant Announcement Contact: GREGoRi Program Team
[email protected]
[email protected]
Similar Government Grants: • GREGoRi Technology Integration Center (U01, Clinical Trials Optional); • GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed); • Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Sch...; • Single Source: Outcomes of Electronic Medical Records and Genomics (eMERGE) Genomic Risk A...; • Limited Competition: Outcomes of Electronic Medical Records and Genomics (eMERGE) Genomic ...; • Near-Term Technology Development for Genome Sequencing - SBIR (R43/R44); • Near-Term Technology Development for Genome Sequencing - STTR (R41/R42); • Revolutionary Genome Sequencing Technologies - The $1000 Genome - SBIR (R43/R44)
More Grants from the National Institutes of Health: • Research Centers in Minority Institutions (RCMI) Coordinating Center (U24 - Clinical Trial...; • Single Source: Post-Stroke Vascular Contributions to Cognitive Impairment and Dementia (VC...; • Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional); • Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal ...; • PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine...